The impact of modified staining method on HER2 immunohistochemical staining for HER2-low breast cancer

被引:2
|
作者
Chen, Yen-Yin [1 ,2 ,3 ,4 ]
Yang, Ching-Fe [3 ,4 ]
Hsu, Chih-Yi [3 ,4 ,5 ]
机构
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, Taipei, Taiwan
[2] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan
[5] Natl Taipei Univ Nursing & Hlth Sci, Coll Nursing, Taipei, Taiwan
关键词
EXPRESSION; FIXATION;
D O I
10.1016/j.pathol.2023.06.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:122 / 124
页数:3
相关论文
共 50 条
  • [21] Prognosis of Japanese Breast Cancer Based on Hormone Receptor and HER2 Expression Determined by Immunohistochemical Staining
    Nakajima, Hiroo
    Fujiwara, Ikuya
    Mizuta, Naruhiko
    Sakaguchi, Koichi
    Hachimine, Yasushi
    Konishi, Eiichi
    Yanagisawa, Akio
    Magae, Junji
    WORLD JOURNAL OF SURGERY, 2008, 32 (11) : 2477 - 2482
  • [22] Prognosis of Japanese Breast Cancer Based on Hormone Receptor and HER2 Expression Determined by Immunohistochemical Staining
    Hiroo Nakajima
    Ikuya Fujiwara
    Naruhiko Mizuta
    Koichi Sakaguchi
    Yasushi Hachimine
    Eiichi Konishi
    Akio Yanagisawa
    Junji Magae
    World Journal of Surgery, 2008, 32 : 2477 - 2482
  • [23] Prognosis of Japanese breast cancer based on hormone receptor and HER2 expression determined by immunohistochemical staining
    Fujiwara, I.
    Nakajima, H.
    Mizuta, N.
    Sakaguchi, K.
    Hachimine, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    de Moura Leite, Luciana
    Cesca, Marcelle Goldner
    Tavares, Monique Celeste
    Santana, Debora Maciel
    Saldanha, Erick Figueiredo
    Guimaraes, Paula Tavares
    Sa, Daniella Dias Silva
    Simoes, Maria Fernanda Evangelista
    Viana, Rafael Lima
    Rocha, Francisca Giselle
    Loose, Simone Klog
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla Albina Zanco
    Mattos, Bruna Raphaeli Silva
    Campos, Fernando Augusto Batista
    Sanches, Solange Moraes
    de Lima, Vladmir Claudio Cordeiro
    Ponde, Noam Falbel
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
  • [25] Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond
    Marchio, Caterina
    Annaratone, Laura
    Marques, Ana
    Casorzo, Laura
    Berrino, Enrico
    Sapino, Anna
    SEMINARS IN CANCER BIOLOGY, 2021, 72 : 123 - 135
  • [26] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    Luciana de Moura Leite
    Marcelle Goldner Cesca
    Monique Celeste Tavares
    Debora Maciel Santana
    Erick Figueiredo Saldanha
    Paula Tavares Guimarães
    Daniella Dias Silva Sá
    Maria Fernanda Evangelista Simões
    Rafael Lima Viana
    Francisca Giselle Rocha
    Simone Klog Loose
    Sinara Figueiredo Silva
    Rafaela Pirolli
    Camilla Albina Zanco Fogassa
    Bruna Raphaeli Silva Mattos
    Fernando Augusto Batista Campos
    Solange Moraes Sanches
    Vladmir Cláudio Cordeiro de Lima
    Noam Falbel Pondé
    Breast Cancer Research and Treatment, 2021, 190 : 155 - 163
  • [27] ER staining levels affect HER2 staining and heterogeneity
    Momoko Akashi
    Rin Yamaguchi
    Hironori Kusano
    Miki Yamaguchi
    Jun Akiba
    Tatsuyuki Kakuma
    Maki Tanaka
    Yoshito Akagi
    Hirohisa Yano
    Breast Cancer, 2021, 28 : 720 - 726
  • [28] ER staining levels affect HER2 staining and heterogeneity
    Akashi, Momoko
    Yamaguchi, Rin
    Kusano, Hironori
    Yamaguchi, Miki
    Akiba, Jun
    Kakuma, Tatsuyuki
    Tanaka, Maki
    Akagi, Yoshito
    Yano, Hirohisa
    BREAST CANCER, 2021, 28 (03) : 720 - 726
  • [29] The frequency of HER2 amplification and the percentage of membrane staining in HER2 2+invasive carcinomas of the breast
    Lee, Andrew H. S.
    Ellis, Ian O.
    VIRCHOWS ARCHIV, 2022, 481 (02) : 327 - 327
  • [30] Impact of immunohistochemistry staining conditions on the incidence of human epidermal growth factor receptor 2 (HER2)-low breast cancer
    Kim, Min Chong
    Kwon, Sun Young
    Jung, Hye Ra
    Bae, Young Kyung
    VIRCHOWS ARCHIV, 2024, : 1117 - 1125